Business
Billionaire investor George Soros may have an interest in Juno Therapeutics, an immunotherapy stock that had its IPO last Friday, multimedia financial services company...
Hi, what are you looking for?
Billionaire investor George Soros may have an interest in Juno Therapeutics, an immunotherapy stock that had its IPO last Friday, multimedia financial services company...
– Bose and Beats are duking it out in the headphones space, but it seems Beats, created by Dr. Dre and Jimmy Iovine,...
– The biotech sector has been outperforming the S&P 500, and some money managers continue to buy even as others are concerned about...
The legendary British supermarket chain, Sainsbury’s might get a new lease on life as shares rose amid talks that Crystal Amber Fund, a U.K...
Billionaire Steve Cohen is investing in the “world’s most hated commodity”–uranium. Motley Fool’s Robert Baillieul thinks that he might be on to...
Billionaire investors are ditching Neflix, Johnson & Johnson and Celgene. Motley Fool writers Leo Sun, George Budwell and Cheryl Swanson discuss the reasons why....
Shares of Groupon rose on Friday following strong earnings, as reported by Motley Fool. Although the stock has struggled, it is up 20% since...
Motley Fool has observed that John Paulson is beefing up his gold holdings, but is this a move worth following? Paulson has bought $1.3...
Jim Cramer, with his Mad Money program running more than ten years at CNBC, is about as famous as big-name money managers...
The following are 3 stocks that have fallen in price, but are worth holding during their journey back up. Motley Fool outlined 3 “fallen...